Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS272
Academic Journal
The article examines the effect of glycemic control on body weight and cardiovascular risk factors. Several reasons for the associated weight gain in various anti-diabetic treatments include defensive snacking, decreased glucosuria, decreased basal metabolic rate and expansion in adipose tissue. New therapeutic agents have been developed to treat type 2 diabetes, and these include incretin-based therapies which have glucagon-like peptide (GLP)-1 receptor agonists. Examples of therapies with GLP-1 agonists include exenatide and liraglutide.


Related Articles

  • ELI LILLY & CO.  // MondayMorning;9/19/2011, Vol. 19 Issue 33, p1 

    The article reports on the statement of Eli Lilly and Co. and Amylin Pharmaceuticals Inc. that patients taking their Bydureon diabetes drug saw improvement in cardiovascular risk factors. It offers that the analysis of late-stage drug trial data showed that Type 2 diabetes patients who received...

  • Weight gain early in life led to cardiovascular disease. Costa, Samantha // Endocrine Today;Apr2013, Vol. 11 Issue 4, p19 

    The article reports that people gaining weight at an early age could face the risk of developing cardiovascular disease (CVD), as discussed by researcher Arjun K. Ghosh at the American College of Cardiology Scientific Sessions held in San Francisco, California from March 9 to 11, 2013.

  • Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Czernichow, S.; Mennen, L.; Bertrais, S.; Hercherg, S.; Oppert, J.M. // International Journal of Obesity & Related Metabolic Disorders;Aug2002, Vol. 26 Issue 8, p1138 

    Investigates the relationship between changes in weight and changes in cardiovascular risk factors in adults, taking intentionality of weight loss into account. Longitudinal study in middle-aged French subjects from the SU.VI.MAX cohort; Measurement of weight, height, blood pressure, serum...

  • The risk of developing the metabolic syndrome is increased in patients receiving conventional antidepressants.  // Drugs & Therapy Perspectives;Sep2011, Vol. 27 Issue 9, p20 

    The metabolic syndrome is associated with depressive disorders. In addition, many conventional antidepressants are known to have adverse metabolic effects. Therefore, patients receiving such antidepressants should be monitored regularly for signs of metabolic disturbances.

  • Don't Stop Pumpin'. Claps, Frank // Joe Weider's Muscle & Fitness;Jun2002, Vol. 63 Issue 6, p44 

    Deals with a study which focuses on the risk of weight gained by athletes during their post-bodybuilding period. Weight considered as risk factor of cardiovascular diseases; Effect of weight gain on former bodybuilders.

  • Excess weight gain in the first 18 months of life is associated with later childhood overweight, obesity and greater arterial wall thickness. Stettler, Nicolas; Baumann, Madeleine // Evidence Based Nursing;Jul2014, Vol. 17 Issue 3, p85 

    The article discusses the study which examines the possible association between early makers of cardiovascular disease (CVD) and rapid infancy weight among Australian children. The study involves 395 participants with infants wherein the infants' carotid ultrasounds and blood pressure for...

  • Does Weight Gain After Quitting Smoking Reduce Cardiovascular Benefit?  // Nutrition Health Review: The Consumer's Medical Journal;2013, Issue 109, p3 

    The article presents a study whether weight gain after quitting smoking reduce cardiovascular beneflt.

  • Senescence-induced remodelling in large and small arteries of mice: impact of high-fat diet. Jiménez-Altayó, F.; Dantas, A. P.; Onetti, Y.; Oliveira, M. A.; Carvalho, M. H.; Vila, E. // Proceedings of the Physiological Society;2013, p786P 

    Aging and weight gain are independent cardiovascular risk factors, which have shown to be increasingly associated. We hypothesize that high-fat intake could lead to arterial remodelling similar to that promoted by vascular aging and worsen the remodelling exerted by senescence. For this purpose...

  • Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial. FONSECA, VIVIAN; MCDUFFIE, ROBERTA; CALLES, JORGE; COHEN, ROBERT M.; FEENEY, PATRICIA; FEINGLOS, MARK; GERSTEIN, HERTZEL C.; ISMAIL-BEIGI, FARAMARZ; MORGAN, TIMOTHY M.; POP-BUSUI, RODICA; RIDDLE, MATTHEW C. // Diabetes Care;Aug2013, Vol. 36 Issue 8, p2162 

    OBJECTIVE -- Identify determinants of weight gain in people with type 2 diabetes mellitus (T2DM) allocated to intensive versus standard glycemic control in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS -- We studied determinants of weight gain...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics